GlassScriptPhysician profile
Poonam Ramani
NPI 1033111349
$5,059.29
in general payments reported to CMS, 2019-2025
36 companies · $1,105 in 2025
The $1,105 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.06 · 2020: $28.18 · 2021: $31.21 · 2022: $742 · 2023: $1,441 · 2024: $1,698 · 2025: $1,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,228 · Education: $16.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,227.50 |
| Education | $16.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $759.32 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $747.15 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $735.52 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $573.10 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $334.72 | 2022-2025 | |
| Abbott Laboratories | $216.28 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Xeris Pharmaceuticals, INC. | $161.58 | 2022-2023 | Gvoke Hypopen |
| Otsuka America Pharmaceutical, INC. | $136.56 | 2023-2024 | Rexulti |
| Astellas Pharma US INC | $134.27 | 2019-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.74 | 2021-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $107.83 | 2022-2023 | |
| Amgen INC. | $107.22 | 2023-2024 | Otezla, Repatha |
| Janssen Pharmaceuticals, INC | $102.79 | 2022-2024 | Xarelto, Spravato |
| Abbvie INC. | $101.24 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $99.55 | 2023-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $84.85 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Baxter Healthcare | $55.55 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $38.71 | 2023 | |
| Medtronic, INC. | $37.23 | 2025 | Interstim |
| Dexcom, INC. | $35.71 | 2022-2023 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $35.51 | 2023-2024 | Verquvo, Gardasil, Capvaxive |
| Globus Medical, INC. | $31.30 | 2025 | Senza |
| Ironwood Pharmaceuticals, INC | $29.72 | 2022-2024 | |
| Nevro Corp. | $26.46 | 2024 | Senza |
| Atland Pharmaceuticals, LLC | $25.44 | 2025 | Tolmetin Sodium, Orphenadrine Citrate, Aspirin and Caffeine |
| Global Blood Therapeutics, INC. | $24.85 | 2022 | |
| Idorsia Pharmaceuticals US INC | $24.81 | 2023 | Quviviq |
| Insulet Corporation | $24.49 | 2023 | Omnipod |
| Actelion Pharmaceuticals US, INC. | $22.51 | 2024 | Uptravi, Opsumit |
| Hologic Sales and Service, LLC | $21.76 | 2024 | Aptima |
| Kowa Pharmaceuticals America, INC. | $20.39 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.13 | 2024 | Xifaxan |
| Inogen, INC. | $14.57 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.36 | 2022 | |
| Phathom Pharmaceuticals, INC. | $13.54 | 2024 | Voquezna |
| Avion Pharmaceuticals | $12.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Poonam Ramani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.